Goldman Sachs initiated coverage of Corteva (CTVA) with a Buy rating and $71 price target implying 20% upside. The company is a “high-quality” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results